Company profile
DBV Technologies
On a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™
- Industry
- Biotechnology Research
- Employees
- 235
- Headquarters
- Châtillon, France
- LinkedIn followers
- 20,486
- Office locations
- 2
DBV Technologies company summary
DBV Technologies is a company in the Biotechnology Research industry, headquartered in Châtillon, France. On LinkedIn the company has around 235 employees and 20,486 followers. The company lists 2 office locations. Its listed specialties include Allergy, Food and pediatric allergy, Specific immunotherapy.
What technology does DBV Technologies use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About DBV Technologies
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin. Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy. Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.
Specialties
Where is DBV Technologies located?
DBV Technologies lists 2 office locations.
Compare companies similar to DBV Technologies
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
DBV Technologies dbv-technologies.com | Biotechnology Research | 235 | - | Châtillon, France |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about DBV Technologies
What does DBV Technologies do?
DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, Viaskin™, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the immune system of patients through the skin. Today, we are focused on exploring the use of Viaskin to address food allergies, a devastating condition that afflicts millions of patients. As an important milestone in our journey, we hope to offer the first epicutaneous immunotherapy treatment for peanut allergy. Tomorrow, as pioneers, we will continue to explore the broad applications of this potential new class of immunotherapy, including treatments for patients suffering from inflammatory and autoimmune diseases.
How many employees does DBV Technologies have?
DBV Technologies has around 235 employees on LinkedIn.
Where is DBV Technologies headquartered?
DBV Technologies is headquartered in Châtillon, France.
Where does DBV Technologies have offices?
DBV Technologies lists 2 office locations, including Châtillon, France, FR; Warren, New Jersey, US.
Build a lead list from companies like DBV Technologies
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.